Owner Alexza Pharmaceuticals, Inc.

Inventors Lloyd, Peter M.; Rabinowitz, Joshua, D.; Munzar, Patrik; Skowronski, Roman; Lu, Amy T.; Hale, Ron L.

Agent Davies Collison Cave

Pub. Number AU-B-2003295823

PCT Number PCT/US2003/0374

PCT Pub. Number WO2004/047841

Priority 60/429,404 26.11.02 US

Filing date 20 November 2003

Wipo publication date 18 June 2004

Acceptance publication date 5 November 2009

A61K 31/4515 (2006.01) - having a butyrophenone group in position 1, e.g. haloperidol

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/382 (2006.01) - having six-membered rings, e.g. thioxanthenes

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/5415 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61M 15/00 (2006.01) Inhaling devices

A61P 25/06 (2006.01) Drugs for disorders of the nervous system